Assessing toxicity of intravenous crystalloids in critically Ill patients

JAMA - Journal of the American Medical Association

Volumn 314, Issue 16, 2015, Pages 1695-1697

  Kellum, John A ^a   Shaw, Andrew D ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; INFUSION FLUID; SODIUM CHLORIDE; CREATININE; ISOTONIC SOLUTION;

ACIDOSIS; ACUTE KIDNEY FAILURE; CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; CRYSTALLOID; DRUG SAFETY; EDITORIAL; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERCHLOREMIA; INTRACRANIAL PRESSURE; KIDNEY FUNCTION; META ANALYSIS (TOPIC); METABOLIC ACIDOSIS; MORTALITY; MUSCLE HYPOTONIA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TOXICITY; ADVERSE EFFECTS; BLOOD; CHEMICALLY INDUCED; FEMALE; FLUID THERAPY; MALE;

ACUTE KIDNEY INJURY; CREATININE; FEMALE; FLUID THERAPY; HUMANS; ISOTONIC SOLUTIONS; MALE; SODIUM CHLORIDE;

EID: 84945294453     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.12390     Document Type: Editorial

References (19)

1. Chan L, Slater J, Hasbargen J, Herndon DN, Veech RL, Wolf S. Neurocardiac toxicity of racemic DL-lactate fluids. Integr Physiol Behav Sci. 1994; 29 (4): 383-394.
2. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998; 317(7153): 235-240.
3. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350(22): 2247-2256.
4. Myburgh J, Cooper DJ, Finfer S, et al.; SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007; 357(9): 874-884.
5. Perner A, Haase N, Guttormsen AB, et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 vs Ringer acetate in severe sepsis. N Engl J Med. 2012; 367(2): 124-134.
6. Myburgh JA, Finfer S, Bellomo R, et al.; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367(20): 1901-1911.
7. Shaw AD, Kellum JA. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol. 2013; 8 (3): 497-503.
8. Finfer S, Liu B, Taylor C, et al.; SAFE TRIPS Investigators. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010; 14(5): R185.
9. Cushing H. Concerning the poisonous effect of pure sodium chloride solutions upon the nerve-muscle preparation. Am J Physiol-Legacy Content. 1901; 6(2): 77-90.
10. Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during in vitro hemodilution. Crit Care Med. 2002; 30(1): 157-160.
11. Maitland K, Kiguli S, Opoka RO, et al.; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364(26): 2483-2495.
12. Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest. 2004; 125(1): 243-248.
13. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared with Plasma-Lyte. Ann Surg. 2012; 255(5): 821-829.
14. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of intravenous crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014; 42(7): 1585-1591.
15. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014; 40 (12): 1897-1905.
16. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012; 308(15): 1566-1572.
17. Young P, Bailey M, Beasley R, et al.; for the SPLIT investigators and the ANZICS CTG. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. doi: 10.1001/jama.2015.12334.
18. Zhou F, Peng Z-Y, Bishop JV, Cove ME, Singbartl K, Kellum JA. Effects of fluid resuscitation with 0.9% saline vs a balanced electrolyte solution on acute kidney injury in a rat model of sepsis. Crit Care Med. 2014; 42(4): e270-e278.
19. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012; 256(1): 18-24.